v3.26.1
Financial instruments (Tables)
3 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of financial instruments measured at fair value on recurring basis

The following table represents the fair value hierarchy for the Company’s financial instruments measured at fair value on a recurring basis as of June 30, 2026:

Schedule of financial instruments measured at fair value on recurring basis

 

                     
   As of June 30, 2026 
   Fair Value Measured using 
Particulars   Level 1    Level 2    Level 3    Total 
Financial liabilities:                    
Derivative warrant liabilities       2,422,645        2,422,645 
Convertible Promissory Notes       1,029,374        1,029,374 
Convertible Notes           13,095,363    13,095,363 
Financial liabilities       3,452,019    13,095,363    16,547,382 
Schedule of fair value, liabilities measured on recurring basis, unobservable input reconciliation

The following table presents a reconciliation of the Company’s Level 3 financial instruments measured and recorded at fair value on a recurring basis as of June 30, 2026 for Financial Asset: Forwards Purchase Agreement, and for Financial Liability: Convertible Promissory notes and Convertible Notes.

Schedule of fair value, liabilities measured on recurring basis, unobservable input reconciliation

 

   Financial liability
Convertible Notes
   Financial liability
Convertible Promissory
Notes
 
         
Initial measurement   11,111,110    1,029,374 
Cash receipt        
Change in fair value   1,984,253     
Balance as of June 30, 2026   13,095,363    1,029,374